title: Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
authors.forename: T
authors.initials: T
authors.lastname: Schmook
authors.forename: J
authors.initials: J
authors.lastname: Kraft
authors.forename: B
authors.initials: B
authors.lastname: Benninghoff
authors.forename: I
authors.initials: I
authors.lastname: Nindl
authors.forename: J
authors.initials: J
authors.lastname: Roewert
authors.forename: C
authors.initials: C
authors.lastname: Ulrich
authors.forename: E
authors.initials: E
authors.lastname: Stockfleth
mesh_terms: D000287:Administration, Topical; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; C117268:pimecrolimus; D016559:Tacrolimus